SEC Filing Summary: Midatech Pharma PLC (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Midatech Pharma PLC, a foreign private issuer, for the month of September 2019. The filing date is September 9, 2019. The registrant is headquartered in Cardiff, United Kingdom. Note: The request metadata references "Biodexa Pharmaceuticals Plc," but the filing text explicitly identifies the registrant as "Midatech Pharma PLC."
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a corporate governance event and does not contain financial statements or performance data.
Material Changes
The material change disclosed in this filing is a change in the company's directorate, as detailed in the attached press release dated September 9, 2019.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the announcement of the directorate change.
Key Facts for Investor Verification
- Verify the specific details of the directorate change referenced in Exhibit 99.1 (Press Release dated September 9, 2019).
- Confirm the identity of the new or departing directors to assess potential strategic shifts.
- Note that this filing contains no financial performance data; refer to the most recent Form 20-F for financial metrics.